Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
(Research Context) In controlled laboratory and in-vitro settings, KLOWs four constituent peptides have been examined across several complementary research areas: Tissue repair and regeneration BPC-157 and TB-500 are studied for their roles in fibroblast activity, angiogenesis, and connective tissue remodelling Inflammation modulation KPV (Lys-Pro-Val), a tripeptide derived from the C-terminal region of -melanocyte-stimulating hormone (-MSH), is studied for its ability to suppress NF-B signalling and reduce pro-inflammatory cytokine activity in preclinical models Extracellular matrix support GHK-Cu has been extensively studied in the context of collagen and elastin synthesis, wound healing models, and skin fibroblast activity Cell migration and cytoskeletal dynamics TB-500 (a synthetic fragment of Thymosin Beta-4) is examined for its role in actin regulation and how it influences cell movement and vascular response Gene expression modulation GHK-Cu has been reported in research to influence the expression of over 4,000 genes associated with tissue growth, repair, and immune balance Gut barrier and epithelial integrity Both KPV and BPC-157 have been investigated in models studying mucosal and epithelial barrier function The combined formulation allows researchers to investigate how these complementary mechanisms interact within regenerative and inflammatory research models an advantage over studying each peptide independently
Taking into account the potential risks associated with stopping supplementation can help ensure that the decision is made with full knowledge of the potential consequences
those focused on firmness, skin density, and overall quality rather than aggressive resurfacing
Want the Full Picture
